Sentinel lymph node biopsy technique and multifocal breast cancer - The Aarhus experience

Acta Oncologica

Volumn 46, Issue 5, 2007, Pages 691-696

  Madsen, Anders Husted ^a   Lauridsen, Mette Cathrine ^a   Garne, Jens Peter ^a   Iversen, Annemette ^a   Lernevall, Anders ^a   Buhl, Line ^a   Christiansen, Peer ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; EXPERIENCE; FALSE NEGATIVE RESULT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTIPLE CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASMS, MULTIPLE PRIMARY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 34250360984     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600996454     Document Type: Article

References (43)

1. Grabau DA, Jensen MB, Blichert-Toft M, Andersen JA, Dyreborg U, Carstensen B, et al. The importance of surgery and accurate axillary staging for survival in breast cancer. Eur J Surg Oncol 1998;24:499-507.
2. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-9.
3. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
4. Jastrzebski T, Kopacz A, Lass P. Comparison of peritumoral and subareolar injection of Tc99m sulphur colloid and blue-dye for detection of the sentinel lymph node in breast cancer. Nucl Med Rev Cent East Eur 2002;5:159-61.
5. Lauridsen MC, Garne JP, Hessov I, Sorensen FB, Melsen F, Lernevall A, et al. Sentinel lymph node biopsy in breast cancer-the Aarhus experience. Acta Oncol 2000;39:421-2.
6. Lauridsen MC, Garne JP, Sorensen FB, Melsen F, Lernevall A, Christiansen P. Sentinel lymph node biopsy in breast cancer-experience with the combined use of dye and radioactive tracer at Aarhus University Hospital. Acta Oncol 2004;43:20-6.
7. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23-7.
8. Haid A, Köberle-Wührer R, Knauer M, Burtscher J, Firtzche H, Peschina W, et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: A comparative evaluation. Breast Cancer Res Treat 2002;73:31-6.
9. Isaksson G, Feuk B. Morbidity from axillary treatment in breast cancer-a follow-up study in a district hospital. Acta Oncol 2000;39:335-6.
10. Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 1997;33:193-9.
11. Temple LK, Baron R, Cody HS, III, Fey JV, Thaler HT, Borgen PI, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: A prospective study of 233 women. Ann Surg Oncol 2002;9:654-62.
12. Tengrup I, Tennvall-Nittby L, Christiansson I, Laurin M. Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 2000;39:393-7.
13. Clarke D, Khonji NI, Mansel RE. Sentinel node biopsy in breast cancer: ALMANAC trial. World J Surg 2001;25:819-22.
14. Ross MI. Sentinel node dissection in early-stage breast cancer: Ongoing prospective randomized trials in the USA. Ann Surg Oncol 2001;8(9 Suppl):77S-81S.
15. White RL, Jr, Wilke LG. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 2004;70:420-4.
16. Kuerer HM, Newman LA. Lymphatic mapping and sentinel lymph node biopsy for breast cancer: Developments and resolving controversies. J Clin Oncol 2005;23:1698-705.
17. dbcg. dbcg guidelines 2001. Danish Breast Cancer Group 2001. Available from: URL:www.dbcg.dk
18. Vlastos G, Rubio IT, Mirza NQ, Newman LA, Aurora R, Alderfer J, et al. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol 2000;7:581-7.
19. Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Multicentric mammary carcinoma: Evidence of monoclonal proliferation. Cancer 2002;94:1910-6.
20. Andea AA, Bouwman D, Wallis T, Visscher DW. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2004;100:20-7.
21. Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer 2002;94:1383-90.
22. Koscielny S, Tubiana M, Le MG, Valleron AJ, Mouriesse H, Contesso G, et al. Breast cancer: Relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 1984;49:709-15.
23. Borgstein PJ, Pijpers R, Comans P, van Diest PP, Boom P, Meijer P. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
24. Klimberg VS, Rubio IT, Henry R, Cowan C, Colvert M, Korourian S. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 1999;229:860-4.
25. Mertz L, Mathelin C, Marin C, Gairard B, Chenard MP, Brettes JP, et al. Subareolar injection of 99m-Tc sulfur colloid for sentinel nodes identification in multifocal invasive breast cancer. Bull Cancer 1999;86:939-45.
26. Smith LF, Cross MJ, Klimberg VS. Subareolar injection is a better technique for sentinel lymph node biopsy. Am J Surg 2000;180:434-7.
27. Estourgie SH, Nieweg OE, Olmos RA, Rutgers EJ, Kroon BB. Lymphatic drainage patterns from the breast. Ann Surg 2004;239:232-7.
28. Nieweg OE, Estourgie SH, van Rijk MC, Kroon BB. Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients. J Surg Oncol 2004;87:153-6.
29. Zavagno G, Rubello D, Franchini Z, Meggiolaro F, Ballarin A, Casara D, et al. Axillary sentinel lymph nodes in breast cancer: A single lymphatic pathway drains the entire mammary gland. Eur J Surg Oncol 2005;31:479-84.
30. Kuerer HM, Newman LA. Lymphatic mapping and sentinel lymph node biopsy for breast cancer: Developments and resolving controversies. J Clin Oncol 2005;23:1698-705.
31. Fuhrman GM. Sentinel lymph node mapping and biopsy for ductal carcinoma in situ and other controversial indications. Am Surg 2004;70:403-6.
32. Tousimis E, Van Zee KJ, Fey JV, Hoque LW, Tan LK, Cody III, et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 2003;197:529-35.
33. Goyal A, Newcombe RG, Mansel RE, on behalf of the ALMANAC Trialists Group. Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol 2004;30:475-9.
34. Bergkvist L, Frisell J. Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 2005;92:1221-4.
35. Macmillan RD, Rampaul RS, Lewis S, Evans AJ. Preoperative ultrasound-guided node biopsy and sentinel node augmented node sample is best practice. Eur J Cancer 2004;40:176-8.
36. Podkrajsek M, Music MM, Kadivec M, Zgajnar J, Besic N, Pogacnik A, et al. Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 2005.
37. Mertz L, Mathelin C, Marin C, Gairard B, Chenard MP, Brettes JP, et al. Subareolar injection of 99m-Tc sulfur colloid for sentinel nodes identification in multifocal invasive breast cancer. Bull Cancer 1999;86:939-45.
38. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 2001;357(9250):122.
39. Kim J, Heerdt AS, Cody HS, Van Zee KJ. Sentinel lymph node drainage in multicentrix breast cancer. Breast J 2002;8:356-61.
40. Fernandez K, Swanson M, Verbanac K, Tafra LC. Is sentinel lympadenectomy Accurate in multifocal and multicentric breast cancer. Ann Surg Oncol 2002;9:S16-7.
41. Ozmen V, Muslumanoglu M, Cabioglu N, Tuzlali S, Ilhan R, Igci A, et al. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat 2002;76:237-44.
42. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. J Nucl Med 2003;44:7-10.
43. Kumar R, Potenta S, Alavi A. Sentinel lymph node biopsy in multifocal and multicentric breast cancer. J Am Coll Surg 2004;198:674-6.